| 注册
首页|期刊导航|临床与病理杂志|促红细胞生成素肝细胞激酶受体与ephrin配体及其信号转导在肿瘤中的研究进展

促红细胞生成素肝细胞激酶受体与ephrin配体及其信号转导在肿瘤中的研究进展

殷灵瑜

临床与病理杂志2017,Vol.37Issue(5):1039-1046,8.
临床与病理杂志2017,Vol.37Issue(5):1039-1046,8.DOI:10.3978/j.issn.2095-6959.2017.05.029

促红细胞生成素肝细胞激酶受体与ephrin配体及其信号转导在肿瘤中的研究进展

Research progress in erythropoietin producing hepatocyte kinase receptor and ephrin ligand as well as their signal transduction in cancer

殷灵瑜1

作者信息

  • 1. 徐州医科大学医学技术学院,江苏 徐州221000
  • 折叠

摘要

Abstract

Erythropoietin producing hepatocyte kinase (Eph) receptors and membrane binding ephrin ligands are the largest family of receptor tyrosine kinase,which not only regulate a great deal of physiological functions in organisms,but also participate in the occurrence and development of a variety of diseases.In recent years,there is more and more evidence that tumor development and Eph family members are dosely related to abnormal expression.

关键词

促红细胞生成素肝细胞激酶/ephrin/信号转导

Key words

erythropoietin producing hepatocyte kinase/ephrin/signal transduction

引用本文复制引用

殷灵瑜..促红细胞生成素肝细胞激酶受体与ephrin配体及其信号转导在肿瘤中的研究进展[J].临床与病理杂志,2017,37(5):1039-1046,8.

基金项目

江苏省自然科学基金(BK20160233).This work was supported by Natural Science Foundation of Jiangsu Province,China (BK20160233). (BK20160233)

临床与病理杂志

OACSTPCD

1673-2588

访问量0
|
下载量0
段落导航相关论文